Neuromuscular diseases (NMDs) form a heterogeneous group of pathologies affecting the spinal cord and its tracts, nerve roots as well as motor and sensory peripheral nerves and roots, the neuromuscular junction and muscles. Diagnosis involves the use of a series of sophisticated methods that include: neurophysiological studies, muscle or nerve biopsy with the use of immunohistochemical techniques and others, metabolic analysis and tests, MRI studies, quantification of muscle deficit and in many cases genetic studies.
From the few epidemiological studies that exist in our country, the prevalence of chronic neurodegenerative and/or hereditary pathology is estimated to be of around 60,000 patients throughout Spain.
Jefe de Grupo | Institución consorciada | Detalles |
---|---|---|
Acevedo Arozena, Abraham |
Hospital Universitario de Canarias de Sta. Cruz de Tenerife | View group |
Fernández Chacón, Rafael |
Universidad de Sevilla | View group |
Infante Cebeiro, Jon |
Instituto de Investigación Marqués de Valdecilla, Santander | View group |
López de Munain Arregui, Adolfo |
Instituto de Investigación Biodonostia, San Sebastián | View group |
Martínez Gil, Ana |
Centro de Investigaciones Biológicas, CSIC de Madrid | View group |
Navarro Acebes, Xavier |
Universidad Autónoma de Barcelona | View group |
Osta Pinzolas, Rosario |
Fundacion Instituto de Investigación Sanitaria Aragón de Zaragoza | View group |
Paradas López, Carmen |
Instituto de Biomedicina de Sevilla (IBIS) de Sevilla | View group |
Program 3 is coordinated by Drs. Rafael Fernández Chacón (University of Seville) and Carmen Paradas (Seville Institute of Biomedicine (IBIS).